Tirzepatide's activity at both the GIP and GLP-1 receptors is part of a patented, peptide-based product, and follow-on versions must still demonstrate comparable pharmacokinetics, pharmacodynamics, and immunogenicity
This product is not FDA approved and is not classified as a drug, food, or cosmetic
End Timely insights and specialist analysis on the risks shaping tomorrow's insurance landscape Read more
Targeting the brain directly: Experiments involving the direct injection of GLP-1 into the brain, or the selective activation of central GLP-1-producing neurons, have consistently shown a strong link between central GLP-1 action and reduced food intake
Belle Health LLC is a telehealth company based in Draper, Utah, at 621 E 12300 S, Suite B